| 000 | 01513 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250518080325.0 | ||
| 264 | 0 | _c20200929 | |
| 008 | 202009s 0 0 eng d | ||
| 022 | _a1643-3750 | ||
| 024 | 7 |
_a10.12659/MSM.920371 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhou, Jiong | |
| 245 | 0 | 0 |
_aIndirect Regulation and Equilibrium of p35 and p40 Subunits of Interleukin (IL)-12/23 by Ustekinumab in Psoriasis Treatment. _h[electronic resource] |
| 260 |
_bMedical science monitor : international medical journal of experimental and clinical research _cJan 2020 |
||
| 300 |
_ae920371 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aDermatologic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-12 Subunit p40 _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPsoriasis _xdrug therapy |
| 650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 |
_aUstekinumab _xtherapeutic use |
| 700 | 1 | _aShen, Ji-Yang | |
| 700 | 1 | _aLiu, Lun-Fei | |
| 700 | 1 | _aChen, Ji-Su | |
| 700 | 1 | _aDou, Ting-Ting | |
| 700 | 1 | _aZheng, Min | |
| 700 | 1 | _aCai, Sui-Qing | |
| 773 | 0 |
_tMedical science monitor : international medical journal of experimental and clinical research _gvol. 26 _gp. e920371 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.12659/MSM.920371 _zAvailable from publisher's website |
| 999 |
_c30492029 _d30492029 |
||